while ongoing research is evaluating the optimal thrombolytic agent as well as the possible role of heparin , it is already clear that the use of aspirin with thrombolytic therapy will significantly decrease reinfarction , stroke , and vascular mortality in suspected evolving mi .
C0004057
aspirin
C0027051
mi